CytoCore to merge with another maker of cancer diagnostic equipment

SHARE CytoCore to merge with another maker of cancer diagnostic equipment

CytoCore has agreed to acquire Orlando-based Medite Group, another maker of cancer diagnostic equipment, in an all stock deal.

“The new demands being placed on labs resulting from the passage of the Affordable Care Act, and the 1.6 million new cancer cases (2012) in the U.S., the combined company will leverage its expertise to continue developing new cancer diagnostic tools to improve early detection of these cancers,” the companies said in a joint statement.

Medite shareholders will control 80 percent of the combined company, which will be based in Orlando. The purpose of the reverse merger is Medite will gain CytoCore’s U.S. stock listing, spokeswoman Janine McCargo told the Orlando Business Journal.

h/t Chicago Business Journal

The Latest
A modern blimp requires no pilot, little or no fuel, creates no noise, and can hold multiple cameras capable of independently tracking carjackers and criminals.
Morel hit a two-run homer in the victory against the Reds on Wednesday after Cubs manager David Ross moved him to the bottom of the batting order.
It’s unclear if Griffin will continue his heavy spending in Illinois politics after he and his Citadel hedge fund have packed up and left for Miami. But what was obvious was that his latest big bet on elections in this state was a big failure, up and down the ballot.
Kopech gave up two runs in the first on Mike Trout’s RBI double and his own error covering first base trying to finish a double play, allowing Trout to score. Two more runs on Luis Renfigo’s homer made it 4-0.